Breast Cancer Clinical Trial

Tear Based Sample Collection Breast Cancer Detection

Summary

This study aims to collect tear samples from 50 women who have been recently diagnosed with breast cancer.

View Full Description

Full Description

Namida Lab, Inc. is a biotechnology company located in Fayetteville, AR, with a certified, high-complexity CLIA lab. In January of 2021, Namida Lab, Inc. completed the analytical and clinical validation of a tear-based biological screening test for breast cancer based on proteins from tears. The validation process was carried out manually and now needs to be conducted on the Hamilton StarPlus automated ELISA system. To complete the robot validation, Namida Lab, Inc. needs fifty (50) tear samples collected from women recently diagnosed with breast cancer but who have not undergone any treatment.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Individual is an adult woman and has recently been diagnosed with breast cancer.

Exclusion Criteria:

Individual is excluded if they have already started treatment for the breast cancer diagnosis.
Age less than 18 or more than 100 years.

Study is for people with:

Breast Cancer

Estimated Enrollment:

50

Study ID:

NCT04974567

Recruitment Status:

Active, not recruiting

Sponsor:

Namida Lab

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

UTMB Health
Galveston Texas, 77555, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

50

Study ID:

NCT04974567

Recruitment Status:

Active, not recruiting

Sponsor:


Namida Lab

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider